

Potential short squeeze plays gained steam in 2021, continued throughout 2022 and remained a focus of traders looking for the next big move. High short interest...
You can purchase shares of Aytu BioPharma (NASDAQ:AYTU) through any online brokerage.
Other companies in Aytu BioPharma’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Aytu BioPharma has a consensus price target of $10.00.
The stock price for Aytu BioPharma (NASDAQ: AYTU) is $1.99 last updated October 21, 2026 at 5:02 PM EDT.
There are no upcoming dividends for Aytu BioPharma.
Aytu BioPharma does not have any upcoming earnings scheduled.
There is no upcoming split for Aytu BioPharma.
Aytu BioPharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Aytu BioPharma Inc is a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients. It has single operating segment. Its product portfolio includes EXXUA,...